Celltrion Pharm Inc. (KOSDAQ:A068760) said it is in talks with undisclosed potential buyers over its controlling stake sale. Celltrion said in a regulatory filing that Celltrion's largest shareholder signed a contract with JP Morgan for the management of the planned stake sale and concrete talks are underway with potential buyers.